These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35013064)

  • 41. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
    Ikeda Y; Aihara K; Yoshida S; Sato T; Yagi S; Iwase T; Sumitomo Y; Ise T; Ishikawa K; Azuma H; Akaike M; Kato S; Matsumoto T
    Endocrinology; 2009 Jun; 150(6):2857-64. PubMed ID: 19196803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation.
    Jansen HJ; McRae MD; Mackasey M; Rose RA
    Front Physiol; 2022; 13():1021807. PubMed ID: 36388100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation.
    Song S; Zhang R; Mo B; Chen L; Liu L; Yu Y; Cao W; Fang G; Wan Y; Gu Y; Wang Y; Li Y; Yu Y; Wang Q
    J Mol Cell Cardiol; 2019 Oct; 135():119-133. PubMed ID: 31408621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2016 Jan; 20(1):48-57. PubMed ID: 26515045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.
    Antunes TT; Callera GE; He Y; Yogi A; Ryazanov AG; Ryazanova LV; Zhai A; Stewart DJ; Shrier A; Touyz RM
    Hypertension; 2016 Apr; 67(4):763-73. PubMed ID: 26928801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NLRP3 Deletion Attenuated Angiotensin II-Induced Renal Fibrosis by Improving Mitochondrial Dysfunction and Endoplasmic Reticulum Stress.
    Zhang Y; Liu Y; Bi X; Hu C; Ding W
    Nephron; 2021; 145(5):518-527. PubMed ID: 34062539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway.
    Zhu X; Zhang X; Cong X; Zhu L; Ning Z
    Cardiol Res Pract; 2021; 2021():9935310. PubMed ID: 34422410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K/AKT signaling.
    Yue J; Zhao X
    Biomed Pharmacother; 2020 Feb; 122():109701. PubMed ID: 31918274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
    Liu E; Xu Z; Li J; Yang S; Yang W; Li G
    Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.
    Tamarat R; Silvestre JS; Kubis N; Benessiano J; Duriez M; deGasparo M; Henrion D; Levy BI
    Hypertension; 2002 Mar; 39(3):830-5. PubMed ID: 11897773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation.
    Purohit A; Rokita AG; Guan X; Chen B; Koval OM; Voigt N; Neef S; Sowa T; Gao Z; Luczak ED; Stefansdottir H; Behunin AC; Li N; El-Accaoui RN; Yang B; Swaminathan PD; Weiss RM; Wehrens XH; Song LS; Dobrev D; Maier LS; Anderson ME
    Circulation; 2013 Oct; 128(16):1748-57. PubMed ID: 24030498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time series RNA-seq analysis identifies MAPK10 as a critical gene in diabetes mellitus-induced atrial fibrillation in mice.
    Liu F; Deng Y; Zhao Y; Li Z; Gao J; Zhang Y; Yang X; Liu Y; Xia Y
    J Mol Cell Cardiol; 2022 Jul; 168():70-82. PubMed ID: 35489387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II-Induced Hypertension.
    Callera GE; Antunes TT; He Y; Montezano AC; Yogi A; Savoia C; Touyz RM
    Hypertension; 2016 Nov; 68(5):1179-1190. PubMed ID: 27620391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological blockage of ICAM-1 improves angiotensin II-induced cardiac remodeling by inhibiting adhesion of LFA-1
    Lin QY; Lang PP; Zhang YL; Yang XL; Xia YL; Bai J; Li HH
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1301-H1311. PubMed ID: 31729904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin II in atrial structural remodeling: the role of Ang II/JAK/STAT3 signaling pathway.
    Zheng L; Jia X; Zhang C; Wang D; Cao Z; Wang J; Du X
    Am J Transl Res; 2015; 7(6):1021-31. PubMed ID: 26279747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway.
    Liu L; Geng J; Zhao H; Yun F; Wang X; Yan S; Ding X; Li W; Wang D; Li J; Pan Z; Gong Y; Tan X; Li Y
    Cell Physiol Biochem; 2015; 36(5):2039-50. PubMed ID: 26202363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
    De Ciuceis C; Amiri F; Brassard P; Endemann DH; Touyz RM; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2106-13. PubMed ID: 16100037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
    Chhabra KH; Xia H; Pedersen KB; Speth RC; Lazartigues E
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E874-84. PubMed ID: 23462816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.